Sa Xiao | Pharmaceutical Science | Best Researcher Award

Posted on by Shen Awards

Dr. Sa Xiao | Pharmaceutical Science | Best Researcher Award

Chief Pharmacist, Clinical pharmacist from The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, China

Sa Xiao is an experienced Clinical Pharmacist currently working at the Department of Pharmacy, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology, Foshan, Guangdong, China. she has dedicated her career to clinical pharmacy with a focus on providing quality patient care and optimizing pharmaceutical practices. Sa Xiao holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmaceutical Engineering. Over the past five years and seven months, she has consistently contributed to clinical pharmacy, focusing on improving therapeutic outcomes and pharmaceutical interventions. Sa Xiao’s role places her at the intersection of clinical application and pharmaceutical research, where she works to enhance drug therapy effectiveness and patient safety. Her work contributes directly to hospital-based pharmaceutical care and supports interdisciplinary collaboration in medical settings. Sa Xiao’s background equips her with both theoretical knowledge and practical clinical experience, positioning her as a valuable asset in the healthcare system. While her current profile emphasizes her clinical expertise, expanding her research portfolio could further elevate her impact in the pharmaceutical field. Her dedication, professional growth, and potential for further research contributions make her a promising candidate for recognition in her domain.

Professional Profile

Education

Sa Xiao has built a strong academic foundation that supports her professional excellence in clinical pharmacy. She began her higher education journey at Huzhou Normal University, where she pursued a Bachelor’s degree in Pharmaceutical Engineering from September 2012 to June 2016. This program provided her with essential knowledge of pharmaceutical sciences, drug formulation, and pharmaceutical manufacturing processes. Her education at this stage focused on understanding drug properties, production, and the basic principles that guide pharmaceutical development. After completing her undergraduate studies, Sa Xiao advanced her academic qualifications by enrolling in Guangdong Medical University, where she earned her Master’s degree in Pharmacology from September 2016 to June 2019. This graduate program allowed her to delve deeper into the study of drug actions, mechanisms, and pharmacokinetics. Through her Master’s studies, she developed a comprehensive understanding of clinical pharmacology, which now directly supports her work as a clinical pharmacist. Both her degrees are recognized by the Ministry of Education, China, affirming the academic rigor and credibility of her educational background. Her academic journey demonstrates a seamless transition from pharmaceutical engineering to clinical application, providing her with the necessary expertise to excel in both pharmaceutical sciences and patient-centered clinical practice.

Professional Experience

Sa Xiao has gained substantial professional experience as a Clinical Pharmacist, holding this role since July 2019 at the Department of Pharmacy, The Sixth Affiliated Hospital, School of Medicine, South China University of Technology. With over five years of experience, she has developed a deep understanding of clinical pharmacy operations, patient care protocols, and hospital pharmaceutical services. Her responsibilities likely include reviewing prescriptions, optimizing medication therapies, ensuring the safe and effective use of drugs, and collaborating with medical teams to enhance patient outcomes. Working in a hospital affiliated with a reputable university has provided her with exposure to clinical research, medical education, and interdisciplinary cooperation. Sa Xiao’s experience is not limited to routine pharmacy tasks; her role also requires ongoing learning and adaptation to the latest pharmaceutical guidelines and therapeutic advancements. Her career has been characterized by dedication to improving patient care and supporting evidence-based clinical decisions. While her profile currently focuses on clinical responsibilities, there is potential for her to expand her contributions to include scientific publications, research studies, and leadership in pharmaceutical innovations. Her professional track record reflects commitment, consistency, and the ability to thrive in a demanding healthcare environment.

Research Interest

Sa Xiao’s research interests are rooted in clinical pharmacy and pharmacology, with a focus on optimizing drug therapies, enhancing patient safety, and improving pharmaceutical care within hospital settings. Her academic and professional background suggests a strong interest in therapeutic drug monitoring, drug interactions, and evidence-based medication management. She is likely driven to explore methods for improving the clinical efficacy of pharmacological treatments and minimizing adverse drug reactions. Additionally, she may be interested in research concerning personalized medicine, dosage adjustments for specific patient populations, and clinical outcomes related to pharmaceutical interventions. Her experience as a clinical pharmacist positions her to contribute valuable insights into hospital-based drug management, prescription review processes, and the practical challenges faced in clinical settings. Future research could also include comparative studies on the effectiveness of different pharmacological treatments and the implementation of clinical pharmacy protocols to improve patient care. By aligning her clinical expertise with focused research initiatives, Sa Xiao has the potential to contribute to both national and international discussions in the field of clinical pharmacology and pharmacy practice. Expanding her research interests to cover these areas would significantly strengthen her academic and professional profile.

Research Skills

Sa Xiao possesses a range of research skills that align with her clinical pharmacy background. Her academic training in pharmacology provided her with expertise in drug action mechanisms, pharmacokinetics, and pharmacodynamics, which are essential for conducting clinical pharmaceutical research. She likely has experience in analyzing clinical data, reviewing case studies, and evaluating therapeutic outcomes in real-world settings. Her role as a clinical pharmacist has refined her skills in prescription auditing, patient counseling, and drug therapy evaluation, which contribute to her ability to design practical, patient-focused research projects. Sa Xiao is also expected to be proficient in using clinical databases, medical literature review systems, and pharmacovigilance tools to support her clinical decision-making and potential research activities. Moreover, she may have developed collaborative skills through working with interdisciplinary teams, which are critical for conducting joint clinical studies and implementing hospital-wide pharmaceutical protocols. To further enhance her research portfolio, acquiring advanced skills in statistical analysis, research methodology, and scientific writing would be beneficial. By building on her current skill set and actively participating in research dissemination through conferences and publications, Sa Xiao can establish herself as a leading contributor in the clinical pharmacy research community.

Awards and Honors

At present, no specific awards or honors have been provided for Sa Xiao. However, her sustained commitment to clinical pharmacy over a period of more than five years at a leading university hospital reflects her professional reliability and growing expertise. Although formal recognitions such as research awards, clinical excellence distinctions, or academic honors have not yet been documented, Sa Xiao’s continuous role in a competitive healthcare environment signifies institutional trust in her capabilities. It is possible that she has received internal recognition for her contributions to patient care, medication management, or quality improvement initiatives within her department. Engaging in national or international pharmaceutical competitions, participating in recognized clinical research projects, and contributing to peer-reviewed publications could open avenues for future awards and honors. Earning formal recognition would not only validate her contributions but also help strengthen her professional profile for broader scientific and clinical acknowledgment. Sa Xiao’s consistent career growth and practical impact within the hospital setting suggest that she is well-positioned to achieve significant honors as she continues to expand her involvement in clinical research and professional development activities in the future.

Conclusion

In conclusion, Sa Xiao is a highly capable clinical pharmacist with a strong educational background and valuable experience in the hospital pharmaceutical sector. Her work at The Sixth Affiliated Hospital, School of Medicine, South China University of Technology demonstrates her ability to apply pharmacological knowledge in a clinical environment, directly benefiting patient care and therapeutic practices. While her current profile is predominantly clinical, there is significant potential for her to make substantial research contributions to the field of clinical pharmacy and pharmacology. Sa Xiao’s foundation in pharmaceutical engineering and pharmacology equips her with both theoretical and practical expertise, which can be further advanced through scientific publications, conference presentations, and research collaborations. By actively participating in research dissemination and seeking broader recognition through professional awards, she can enhance her influence within the scientific and medical communities. Sa Xiao’s dedication, clinical precision, and future research potential position her as an emerging contributor to the advancement of pharmaceutical care and clinical pharmacy research. With further academic engagement and research output, she is likely to achieve greater professional recognition and make impactful contributions to the global healthcare landscape.

Publications Top Notes

1. Depression and Suicide/Self-Injury Signals for Weight Loss Medications: A Disproportionality Analysis of Semaglutide, Liraglutide, and Tirzepatide in FAERS Database

  • Journal: Journal of Affective Disorders

  • Publication Date: 2025-06-14

  • Authors: Wang M, Yang Z, Yan M, Liu S, Xiao S

2. Protective Effects of Aqueous Extract of Wampee Fruit Against Anti-Tubercular Drug-Induced Hepatotoxicity in Rats

  • Journal: Journal of Biological Regulators and Homeostatic Agents

  • Publication Date: 2019-01-01

  • Authors: Guan TM, Xiao S, Liu DC, Liao XH, Li WD, Wu KF, Huang R

 

Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Posted on by Shen Awards

Prof. Rohidas Arote | Pharmaceutical Science | Biotechnology Advancement Award

Dr. Rohidas B. Arote is a distinguished professor in the Center for Nano and Material Sciences at Jain University, Bangalore, India. With over two decades of experience in biotechnology, gene therapy, and drug delivery, he has made substantial contributions to biomedical research. His expertise lies in biomaterials, pharmacology, toxicology, and theranostics, particularly in cancer, immune, and regenerative therapies. Having served as a professor at Seoul National University (SNU), a globally ranked institution, he has led groundbreaking research in non-viral gene delivery systems and targeted drug delivery for cancer therapy. Dr. Arote has secured major research grants, collaborated with international institutions, and delivered invited talks at global conferences. He has received prestigious awards such as the Creative Pioneering Research Award and IAAM Scientist Medal. In addition to his academic achievements, he actively contributes to international scientific societies, reviews for high-impact journals, and organizes leading scientific conferences. With a strong track record of publications, research funding, and innovation, Dr. Arote continues to be a key figure in biomedical and pharmaceutical sciences, advancing cutting-edge solutions for healthcare and drug development.

Professional Profile

Education

Dr. Rohidas B. Arote holds a Ph.D. in Biotechnology (2009) from Seoul National University, South Korea, where he specialized in gene therapy and drug delivery systems. His doctoral research focused on developing non-viral polymeric gene carriers for targeted cancer therapy. Before pursuing his Ph.D., he earned a Master of Science (M.S.) in Pharmacognosy and Phytochemistry (2002) from the University of Mumbai, India, where he gained expertise in natural product chemistry and pharmaceutical formulations. His academic journey began with a Bachelor of Science (B.S.) in Pharmaceutical Sciences (2000) from the University of Pune, India, equipping him with a strong foundation in pharmaceutics, drug formulation, and biotechnology. Throughout his education, he has been a recipient of several prestigious fellowships, including the Brain Korea (BK21) Fellowship (2008) and the Korea Science and Engineering Fellowship (KOSEF) (2005). He was also a GATE Scholar in Pharmacy (2000), a competitive national-level qualification exam conducted by IIT Kharagpur, India. His interdisciplinary academic background, spanning biotechnology, pharmaceutical sciences, and biomedical engineering, has enabled him to develop innovative solutions in gene therapy, biomaterials, and targeted drug delivery.

Professional Experience

Dr. Rohidas B. Arote has over 20 years of academic and research experience across prestigious institutions worldwide. He is currently a Professor at the Center for Nano and Material Sciences, Jain University, Bangalore (2021-present), where he leads cutting-edge research in nanomedicine and biomaterials. Prior to this, he served at Seoul National University (SNU), South Korea, as an Associate Professor (2017-2020) and Assistant Professor (2010-2017), where he developed gene delivery technologies for cancer therapy. He also worked as a Research Associate (2009-2010) at SNU, focusing on polymeric carriers for gene therapy. In addition, he held visiting professor positions at King Abdullah University of Science and Technology (KAUST), Saudi Arabia (2019-2020), and the Indian Institute of Science (IISc), Bangalore (2019-2020), contributing to advanced biomedical research. Early in his career, he gained industry experience as a Formulation & Development Scientist at Ajanta Pharma Ltd, Mumbai (2003-2004). His diverse academic, research, and industry experience has made him a leader in drug delivery, biomaterials, and biomedical engineering.

Research Interests

Dr. Rohidas B. Arote’s research focuses on gene therapy, drug delivery, biomaterials, biomedical engineering, pharmacology, toxicology, and theranostics. He is particularly interested in developing novel non-viral gene delivery systems for targeted cancer therapy. His work involves designing biodegradable polymeric nanocarriers for effective gene transfection, with applications in cancer, immune, and regenerative therapies. He explores nanotechnology-based drug delivery to enhance the bioavailability and therapeutic efficacy of pharmaceuticals. Additionally, he investigates biocompatible materials for tissue engineering and regenerative medicine, contributing to the development of next-generation biomaterials for medical applications. His interdisciplinary research bridges biotechnology, materials science, and pharmaceutical sciences, addressing critical challenges in disease treatment and drug delivery. Through collaborations with global research institutions, he continues to push the boundaries of biomedical research by integrating nanomedicine, molecular biology, and bioengineering to develop innovative therapeutic strategies.

Research Skills

Dr. Rohidas B. Arote possesses a diverse set of advanced research skills in biomedical and pharmaceutical sciences. He is an expert in nanotechnology-based drug delivery, specializing in the synthesis and characterization of biodegradable polymers for gene therapy applications. He has expertise in molecular biology techniques, including gene cloning, siRNA delivery, and CRISPR-based genome editing. His skills extend to polymeric biomaterials design, nanoparticle synthesis, and surface modification for targeted drug delivery. He is proficient in in vitro and in vivo models for evaluating gene expression, drug efficacy, and toxicity in preclinical studies. Additionally, he has experience in high-throughput screening, bioinformatics, and computational modeling for drug formulation optimization. His research involves the development of multifunctional polymeric carriers, receptor-mediated drug targeting, and biodegradable materials for regenerative medicine. His strong analytical and problem-solving abilities have enabled him to successfully secure research funding, publish in top-tier scientific journals, and contribute to cutting-edge biomedical innovations.

Awards and Honors

Dr. Rohidas B. Arote has received numerous prestigious awards for his pioneering research in gene therapy and biomaterials. He was honored with the Creative Pioneering Research Award (2017) from Seoul National University, recognizing his innovative contributions to biomedical research. He also received the IAAM Scientist Medal (2017) from the International Association of Advanced Materials, highlighting his excellence in advanced materials and nanomedicine. Other notable accolades include the Research Excellence Award (2010) from the Research Institute for Agriculture and Life Sciences and the Young Scientist Award (2008) from the 16th POLYCHAR: World Forum on Advanced Materials. He has been a Brain Korea (BK21) Fellow (2008) and received the Korea Science and Engineering Fellowship (KOSEF) (2005). His early academic achievements include being a GATE Scholar in Pharmacy (2000), a highly competitive national-level distinction. These awards reflect his outstanding research contributions, leadership in academia, and dedication to advancing biomedical sciences.

Conclusion

Dr. Rohidas B. Arote is an exceptional researcher and academic leader with a remarkable career spanning over two decades in biotechnology, gene therapy, and drug delivery. His contributions in biomaterials, nanomedicine, and regenerative therapies have significantly advanced the field of biomedical sciences. Through his research, funding acquisitions, and scientific collaborations, he has played a crucial role in developing novel drug delivery systems for cancer therapy. His achievements in securing high-impact publications, international awards, and research grants showcase his dedication to scientific excellence. In addition to his research, he has contributed as a peer reviewer, conference organizer, and mentor, shaping the next generation of biomedical researchers. As a professor at Jain University, Bangalore, and a former faculty member at Seoul National University, he continues to lead groundbreaking research in nanomedicine. With his strong academic background, innovative research, and global scientific impact, Dr. Arote stands as a deserving candidate for prestigious research awards, making a lasting impact in healthcare and pharmaceutical sciences.

Publications Top Notes

  1. Title: Microfluidics in Bioanalytical Chemistry
    Authors: R. Nisarga, P.P. Pandit, J.N. Sangshetti, R.B. Arote
    Year: Not provided

  2. Title: Exploring Antibiofilm Potential of Some New Imidazole Analogs Against C. Albicans: Synthesis, Antifungal Activity, Molecular Docking and Molecular Dynamics Studies
    Authors: S.K. Pathan, A.V. Shelar, S.U. Deshmukh, R.H. Patil, J.N. Sangshetti
    Year: 2023
    Citations: 1

  3. Title: In Silico Structure-Based Drug Design Approach to Find Potential Hits in Ventilator-Associated Pneumonia Caused by Pseudomonas aeruginosa
    Authors: M.G. Damale, R.B. Patil, S.A. Ansari, R.B. Arote, J.N. Sangshetti
    Year: 2022
    Citations: 2

  4. Title: Efficient Gene Transfection to Lung Cancer Cells via Folate-PEI-Sorbitol Gene Transporter
    Authors: K. Cho, S. Kim, H. Chun, A. Lee, R.B. Arote
    Year: 2022
    Citations: 6

  5. Title: Development of Novel, Biocompatible, Polyester Amines for Microglia-Targeting Gene Delivery
    Authors: B. Choi, M. Ahn, S. Hong, R.B. Arote, S.J. Lee
    Year: 2021
    Citations: 1

  6. Title: Insights of Tankyrases: A Novel Target for Drug Discovery
    Authors: M.G. Damale, S.K. Pathan, D.B. Shinde, R.B. Arote, J.N. Sangshetti
    Year: 2020
    Citations: 26

  7. Title: Boric Acid: A Versatile Catalyst in Organic Synthesis
    Authors: S.K. Pathan, P.R. Mahaparale, S.U. Deshmukh, R.B. Arote, J.N. Sangshetti
    Year: Not provided
    Citations: 5

Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Posted on by Shen Awards

Dr. Mycal Dutta | Pharmaceutical Science | Best Researcher Award

Associate Professor at University of Science and Technology (USTC), Bangladesh

Dr. Mycal Dutta is an accomplished Associate Professor in the Department of Pharmacy at the University of Science and Technology Chittagong (USTC), Bangladesh. With nearly fourteen years of experience in academia, research, and professional practice, he has made significant contributions to pharmaceutical sciences. Dr. Dutta earned his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. His expertise spans pharmaceutical technology, microbiology, and clinical pharmacy. He has published 36 research papers in national and international journals, focusing on bioactive phytochemicals, drug formulation, and pharmacological investigations. As a registered “A” Grade Pharmacist, he actively contributes to professional training and advisory committees. His research interests include the isolation of medicinal plant compounds, computational drug design, and molecular docking studies. Dr. Dutta has received several research grants, including government-funded projects on ethnomedicinal plants. Apart from his academic roles, he has been involved in organizing scientific conferences and student welfare activities. His commitment to teaching, research, and pharmaceutical advancements has made him a distinguished figure in the field.

Professional Profile

Education

Dr. Mycal Dutta has a strong academic background in pharmacy. He obtained his Ph.D. in Pharmacy from Jahangirnagar University, Dhaka, in December 2022. Prior to this, he completed his Master of Pharmacy (Thesis) degree from Southern University, Bangladesh, in 2011, achieving a CGPA of 3.6 on a 4.0 scale. He earned his Bachelor of Pharmacy (Hons.) degree from the University of Science and Technology Chittagong (USTC) in 2009, graduating with First Class honors. His foundational education includes a Higher Secondary Certificate (HSC) from Govt. Hazi Muhammad Mohsin College, Chittagong, with a GPA of 4.70 out of 5.00 in 2004, and a Secondary School Certificate (SSC) from Collegiate School, Chittagong, with a GPA of 4.38 out of 5.00 in 2002. His educational journey reflects his dedication to academic excellence and pharmaceutical sciences.

Professional Experience

Dr. Mycal Dutta has extensive teaching and research experience in the field of pharmacy. He has been serving as an Associate Professor at the University of Science and Technology Chittagong (USTC) since July 2023. Previously, he worked as an Assistant Professor at BGC Trust University Bangladesh for nearly eight years (2015–2023) and as a Lecturer at the same institution for almost five years (2011–2015). In addition to his teaching roles, he has contributed significantly to academic administration, including serving as an advisor in the Student Welfare Advisory Committee at USTC and as Chief Advisor of the Career Development and Placement Club at BGC Trust University. His professional contributions extend to chairing scientific and publication committees for national conferences and participating in examination committees. His vast experience demonstrates his dedication to pharmacy education and academic leadership.

Research Interests

Dr. Mycal Dutta’s research interests focus on pharmacological and phytochemical investigations of medicinal plants. His work involves compound isolation using techniques such as Nuclear Magnetic Resonance (NMR) and Gas Chromatography-Mass Spectrometry (GC-MS). He is particularly interested in computational drug discovery, molecular docking, Quantitative Structure-Activity Relationship (QSAR) modeling, and ADME/T property analysis of natural compounds. His research aims to bridge wet lab and dry lab approaches to develop therapeutic solutions from natural products. He also explores antimicrobial studies, aseptic techniques, bacterial staining, and in vitro and in vivo pharmacological investigations. His research contributions significantly advance the understanding of bioactive phytochemicals and their therapeutic potential.

Research Skills

Dr. Mycal Dutta possesses a diverse range of research skills, including microbiological techniques such as aseptic handling, bacterial staining, and antimicrobial sensitivity testing. He is proficient in computational drug design, protein modeling, and molecular simulations. His technical expertise extends to animal research, including transgenic and knockout mouse models. He is skilled in using various molecular modeling and Computer-Aided Drug Design (CADD) software. Additionally, he has extensive experience with statistical analysis tools such as GraphPad Prism and SPSS. His proficiency in these areas enables him to conduct high-quality research and mentor students in advanced pharmaceutical investigations.

Awards and Honors

Dr. Mycal Dutta has received several prestigious research grants and recognitions. He was awarded the R&D Grant for Science and Technology (2022–2023) from the Ministry of Science and Technology, Bangladesh, for his research on bioactive phytochemicals. Additionally, he secured a research grant from BGC Trust University Bangladesh in 2017 to support his Ph.D. research. His contributions to pharmaceutical research have been acknowledged through numerous publications in high-impact journals. He has also played a key role in organizing national conferences and scientific symposiums. His commitment to research and academia has earned him a strong reputation in the field of pharmaceutical sciences.

Conclusion

Dr. Mycal Dutta is a dedicated researcher, educator, and pharmaceutical scientist committed to advancing pharmaceutical education and research. With nearly fourteen years of experience, he has made remarkable contributions to pharmacology, phytochemistry, and drug discovery. His extensive research on medicinal plants and computational drug design has positioned him as a leading expert in the field. His passion for teaching, mentoring students, and conducting groundbreaking research continues to impact the pharmaceutical sciences significantly. Through his academic leadership, professional affiliations, and research initiatives, he remains at the forefront of pharmaceutical innovation and education.

Publications Top Notes

  1. Yusuf, A., Shaikat, M. A., Bhuiya, M. A. M., Dutta, M., Nath, A. K., & Dash, P. R. (2023). Utilizing the Medicinal Properties of Delonix regia for Diseases and Beyond: A Review of its Phytochemistry and Pharmacology. Tropical Journal of Natural Product Research, 7(12), 5355–5365. DOI: 10.26538/tjnpr/v7i12.2

  2. Malini, S., Raj, K., Madhumathy, S., El-Hady, K. M., Islam, S., & Dutta, M. (2022). Bioinspired Advances in Nanomaterials for Sustainable Agriculture. Journal of Nanomaterials, 2022, Article ID 8926133. DOI: 10.1155/2022/8926133

  3. Vaidya, S., Jeengar, M., Wadaan, M. A., Mahboob, S., Kumar, P., Reece, L. M., Bathula, S. R., & Dutta, M. (2022). Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 9231641. DOI: 10.1155/2022/9231641

  4. Jadhav, V., Bhagare, A., Wahab, S., Lokhande, D., Vaidya, C., Dhayagude, A., Khalid, M., Aher, J., Mezni, A., & Dutta, M. (2022). Green Synthesized Calcium Oxide Nanoparticles (CaO NPs) Using Leaves Aqueous Extract of Moringa oleifera and Evaluation of Their Antibacterial Activities. Journal of Nanomaterials, 2022, Article ID 9047507. DOI: 10.1155/2022/9047507

  5. Jadhav, V., Bhagare, A., Ali, I. H., Dhayagude, A., Lokhande, D., Aher, J., Jameel, M., & Dutta, M. (2022). Role of Moringa oleifera on Green Synthesis of Metal/Metal Oxide Nanomaterials. Journal of Nanomaterials, 2022, Article ID 2147393. DOI: 10.1155/2022/2147393

  6. Alharthy, S. A., Shams Tabrez, S., Ahmed A. Mirza, A. A., Torki A. Zughaibi, Firoz, C. K., & Dutta, M. (2022). Sugiol Suppresses the Proliferation of Human U87 Glioma Cells via Induction of Apoptosis and Cell Cycle Arrest. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID 7658899. DOI: 10.1155/2022/7658899

  7. Dutta, M., Akter, T., Nezam, M., Paul, A., & Rana, M. S. (2022). In silico Molecular Docking and ADME/T Analysis of Selected Bioactive Compounds from Leucas zeylanica against Breast Cancer. BGC Trust University Journal, 6, 51–66.

  8. Dutta, M., Tareq, A. M., Rakib, A., Mahmud, S., Sami, S. A., Mallick, J., Islam, M. N., Majumder, M., Uddin, M. Z., Alsubaie, A., & Almalki, A. S. (2021). Phytochemicals from Leucas zeylanica Targeting Main Protease of SARS-CoV-2: Chemical Profiles, Molecular Docking, and Molecular Dynamics Simulations. Biology, 10(8), 789. DOI: 10.3390/biology10080789

  9. Dutta, M., Nezam, M., Chowdhury, S., Rakib, A., Paul, A., Sami, S. A., Uddin, M. Z., Rana, M. S., Hossain, S., Effendi, Y., Idroes, R., Tallei, T. E., Alqahtani, A. M., & Emran, T. B. (2021). Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach. Frontiers in Molecular Biosciences, 8, 625391. DOI: 10.3389/fmolb.2021.625391

  10. Rakib, A., Paul, A., Ahmed, S., Chy, M. N. U., Baral, S. K., Majumder, M., Tareq, A. T., Amin, M. N., Shahriar, A., Uddin, M. Z., Dutta, M., Tallei, T. E., Emran, T. B., & Simal-Gandara, J. (2020). Biochemical and Computational Approach of Phytocompounds from Tinospora crispa in the Management of COVID-19: Molecules; 25(17): E3936. DOI: 10.3390/molecules25173936

Na Zhang | Pharmaceutical Science | Best Researcher Award

Posted on by Shen Awards

Prof. Na Zhang | Pharmaceutical Science | Best Researcher Award

Shandong university, China.

Dr. Na Zhang is a distinguished professor at the Institute of Pharmaceutics, Shandong University, China. She earned her Ph.D. in Pharmaceutics from China Pharmaceutical University in July 2004, following her Master’s and Bachelor’s degrees in Pharmacy from Shandong Medical University. Over her extensive career, Dr. Zhang has made significant contributions to the field of pharmaceutics, focusing on innovative drug delivery systems and cancer therapies. With over two decades of academic and research experience, she has established herself as a leader in her field, exemplified by her role as Associate Dean of the School of Pharmaceutical Science. Dr. Zhang’s research has garnered international recognition through numerous publications in high-impact journals, collaborative projects, and successful funding grants. She is dedicated to advancing pharmaceutical education while actively engaging in cutting-edge research that addresses critical healthcare challenges.

Professional Profile

Education

Dr. Na Zhang completed her Ph.D. in Pharmaceutics at the School of Pharmacy, China Pharmaceutical University, in July 2004. Prior to that, she obtained her Master’s degree in Pharmacy in July 1995 from Shandong Medical University, and her Bachelor’s degree in Pharmacy from the same institution in July 1992. Her educational journey has laid a solid foundation for her expertise in pharmaceutics, equipping her with the knowledge and skills to excel in both research and academic settings. Throughout her studies, Dr. Zhang has consistently demonstrated a commitment to academic excellence and innovation, which is evident in her subsequent professional achievements. Her comprehensive educational background enables her to contribute significantly to the fields of drug delivery systems and cancer immunotherapy, fostering the development of advanced pharmaceutical solutions that address pressing health issues.

Professional Experience

Dr. Na Zhang has a robust professional background spanning over two decades in academia and research. Since January 2013, she has served as a professor and Associate Dean at the School of Pharmaceutical Science, Shandong University. Prior to this, she held various positions, including Associate Professor and lecturer at Shandong University and a postdoctoral fellowship at the University of Kansas. Dr. Zhang’s career trajectory illustrates her dedication to the advancement of pharmaceutical sciences through teaching, research, and leadership. Her roles have involved mentoring students and researchers, developing curricula, and contributing to institutional governance. Dr. Zhang’s extensive experience in academia enables her to bridge the gap between scientific research and education, ensuring that her students are well-prepared for future challenges in the pharmaceutical industry.

Research Interests

Dr. Na Zhang’s research interests encompass a wide range of areas within pharmaceutics, particularly focusing on innovative drug delivery systems. She specializes in nano-drug delivery systems, exploring stimuli-responsive carriers for targeted therapy, and cancer immunotherapy. Her work on small molecule-based nanodrugs aims to enhance the efficacy and safety of cancer treatments, addressing critical challenges in current therapeutic approaches. Additionally, she engages in pre-clinical biopharmaceutical evaluation to assess the pharmacokinetics and dynamics of her developed formulations. By combining her expertise in nanotechnology and pharmaceutical sciences, Dr. Zhang seeks to contribute significantly to the field, improving treatment outcomes for patients with cancer and other complex diseases.

Research Skills

Dr. Na Zhang possesses a diverse array of research skills that enhance her effectiveness as a scientist and educator. Her expertise includes the design and development of nano-drug delivery systems, with a particular focus on creating stimuli-responsive carriers. She is proficient in pre-clinical biopharmaceutical evaluation, which involves assessing the pharmacological and therapeutic properties of new drug formulations. Additionally, Dr. Zhang has extensive experience in experimental design, data analysis, and scientific writing, which are essential for conducting high-quality research and publishing in reputable journals. Her collaborative approach fosters interdisciplinary partnerships, enhancing her research’s impact and relevance. Furthermore, her leadership in academic settings enables her to mentor aspiring researchers, sharing her knowledge and skills to cultivate the next generation of pharmaceutical scientists.

Awards and Honors

Dr. Na Zhang’s outstanding contributions to pharmaceutical sciences have earned her numerous awards and honors throughout her career. She has been recognized for her innovative research in nano-drug delivery and cancer immunotherapy, reflecting her commitment to advancing healthcare solutions. Her research has garnered prestigious funding from national bodies, highlighting the significance of her work in the field. Furthermore, Dr. Zhang has received accolades for her excellence in teaching and mentoring, demonstrating her dedication to fostering academic growth among her students. As a published author in high-impact journals, she has received recognition from peers and the broader scientific community for her contributions to advancing pharmaceutical knowledge. Her achievements underscore her influence as a researcher and educator in the pharmaceutical sciences.

Conclusion:

Dr. Na Zhang stands out as an exemplary candidate for the Best Researcher Award due to her significant contributions to pharmaceutical sciences, particularly in nano-drug delivery and cancer immunotherapy. Her impressive publication record, successful acquisition of research funding, and commitment to education reflect her dedication and impact in the field. By addressing the areas for improvement, Dr. Zhang can further enhance her influence and leadership within the global research community. Thus, she is highly deserving of this recognition.

Publications Top Notes

  1. Glypican-3-targeted macrophages delivering drug-loaded exosomes offer efficient cytotherapy in mouse models of solid tumours
    • Authors: Liu, J., Zhao, H., Gao, T., Zhang, N., Liu, Y.
    • Year: 2024
  2. Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal/chemical/immune synergistic therapy against HCC
    • Authors: Yang, H., Mu, W., Yuan, S., Liu, Y., Zhang, N.
    • Year: 2024
  3. Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems
    • Authors: Liu, J., Liu, J., Mu, W., Liu, Y., Zhang, N.
    • Year: 2024
    • Citations: 1
  4. In Situ Hydrogel Modulates cDC1-Based Antigen Presentation and Cancer Stemness to Enhance Cancer Vaccine Efficiency
    • Authors: Gao, T., Yuan, S., Liang, S., Zhang, N., Liu, Y.
    • Year: 2024
  5. Nano-Regulator Inhibits Tumor Immune Escape via the “Two-Way Regulation” Epigenetic Therapy Strategy
    • Authors: Liang, S., Liu, M., Mu, W., Jiang, D., Zhang, N.
    • Year: 2024
    • Citations: 3
  6. Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy
    • Authors: Xia, Z., Mu, W., Yuan, S., Liu, Y., Zhang, N.
    • Year: 2023
    • Citations: 2
  7. Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy
    • Authors: Xia, Y., Fu, S., Ma, Q., Liu, Y., Zhang, N.
    • Year: 2023
    • Citations: 30
  8. Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling
    • Authors: Fu, S., Chang, L., Liu, S., Liu, Y., Zhang, N.
    • Year: 2023
    • Citations: 32
  9. Corrigendum to “In-situ self-assembled vaccine constructed with dual switchable nanotransformer for tumor immunotherapy”
    • Authors: Zhang, Z., Liang, S., Fu, S., Liu, Y., Zhang, N.
    • Year: 2023
  10. Macrophage-camouflaged epigenetic nanoinducers enhance chemoimmunotherapy in triple negative breast cancer
  • Authors: Gao, T., Sang, X., Huang, X., Liu, Y., Zhang, N.
  • Year: 2023
  • Citations: 3

 

 

 

Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Posted on by Shen Awards

Assist Prof Dr. Soha Ismai | Pharmacology, Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assistant Professor, EDA, Egypt

With a solid foundation in pharmacy, including a Bachelor’s, Master’s, and PhD from Cairo University, and a position as Associate Professor, this individual demonstrates exceptional expertise. Their diverse professional experience spans quality control, management, and academic roles, showcasing their leadership and practical knowledge in the pharmaceutical field. Their prolific research output includes numerous publications on advanced drug delivery systems and nanotechnology, reflecting significant contributions to pharmaceutical sciences. Active participation in various training courses, workshops, and international conferences highlights their commitment to continuous professional development. Additionally, their multilingual skills enhance their ability to collaborate in diverse settings. Overall, their comprehensive background in education, research, and professional development, combined with their active engagement in the scientific community, makes them a highly suitable candidate for the Best Researcher Award.

Education

The candidate has a robust educational background that serves as the foundation of their expertise in the field of pharmaceutical sciences. They earned a Bachelor of Pharmacy degree from Cairo University in 1996, graduating with honors, which set the stage for their academic and professional journey. Their pursuit of advanced knowledge led them to complete a Master’s degree in Pharmaceutics in 2007 and later a PhD in 2011, both from the same esteemed institution. This rigorous academic training has equipped them with in-depth knowledge of pharmaceutics, drug formulation, and pharmaceutical analysis. In 2019, they further solidified their academic credentials by attaining the position of Associate Professor, demonstrating their commitment to education, research, and mentorship. Their continuous academic progression reflects a strong commitment to excellence and a desire to contribute significantly to the pharmaceutical sciences, positioning them as a thought leader in their field and a prime candidate for the Best Researcher Award.

Profesional Experience

The candidate has an extensive professional background in the pharmaceutical sector, beginning their career as a QC analyst for raw materials at NODCAR from 1996 to 1999. They then transitioned to academia as a teaching assistant at the Faculty of Pharmacy, October University, in 1999. Between 2000 and 2012, they worked as a QC analyst specializing in physical properties before moving into management roles, including quality manager and deputy lab manager. From 2016 to 2021, they served as a technical manager, demonstrating their expertise in overseeing laboratory operations and maintaining quality standards. Their role expanded further as they joined several committees, contributing to updating pharmaceutical guidelines and developing the Egyptian pharmacopeia. In 2021, they became the lab manager of the physicochemical lab at the Egyptian Drug Authority (EDA), where they continue to lead and innovate in quality control and research.

Research Skill

The candidate possesses exceptional research skills, demonstrated through a prolific publication record in high-impact journals and extensive experience in developing innovative pharmaceutical formulations. They have expertise in designing and conducting complex experimental studies, including the use of advanced methodologies like Box–Behnken design for optimization and in vivo evaluations. Their research work spans various domains, including nanotechnology, ocular drug delivery, and gastroretentive systems, showcasing versatility and a strong ability to adapt to emerging scientific trends. Additionally, their role in supervising master’s and PhD theses highlights their leadership in guiding future researchers. The candidate is also well-versed in utilizing statistical analysis tools and quality-by-design approaches, which are critical for ensuring the rigor and reliability of research findings. Their ability to translate research into practical applications, coupled with active participation in committees that shape pharmaceutical guidelines, underscores a profound impact on both academic and industry standards in the pharmaceutical sciences.

Awards And Recoginition

The individual has received multiple accolades throughout their career, reflecting their outstanding contributions to the field of pharmaceutical sciences. Their expertise in pharmaceutics and dedication to research have been recognized by esteemed institutions and professional bodies. Notably, they have been honored for their innovative work in drug delivery systems and quality management, which have had a significant impact on the pharmaceutical industry. They have been a valuable member of committees responsible for updating pharmaceutical guidelines and establishing national standards, further highlighting their influence and leadership in the field. Additionally, their research publications in renowned international journals have been widely cited, earning them recognition among peers as a leading researcher. Their participation in prestigious conferences and workshops, both as a presenter and a participant, underscores their commitment to continuous learning and sharing knowledge. These recognitions affirm their position as a distinguished professional dedicated to advancing pharmaceutical science and improving healthcare outcomes.

Conclution

The individual’s blend of academic excellence, practical experience, prolific research output, and continuous professional growth makes them a highly suitable candidate for the Best Researcher Award. Their achievements reflect their dedication to advancing pharmaceutical science and their impact on the field.

Publication Top Notes

  1. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency
    • Authors: Nagham H. Kamal, Fatema R. Saber, Abeer Salama, Dalia M. N. Abouhussein, Soha Ismail, Hala M. El-Hefnawy, Meselhy R. Meselhy
    • Year: 2024
    • Citation: Kamal NH, Saber FR, Salama A, Abouhussein DMN, Ismail S, El-Hefnawy HM, Meselhy MR. Enhanced wound healing activity of naturally derived Lagenaria siceraria seed oil binary nanoethosomal gel: formulation, characterization, in vitro/in vivo efficiency. Future Journal of Pharmaceutical Sciences. 2024 Aug 19. doi:10.1186/s43094-024-00678-2.
  2. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment
    • Authors: Abeer Khattab, Soha Ismail, Areeg M. Abd-Elrazek
    • Year: 2024
    • Citation: Khattab A, Ismail S, Abd-Elrazek AM. Mucoadhesive Chitosan Composite Sponge as a Carrier for β-Sitosterol Cubosomes for Thermal Burn Treatment. AAPS PharmSciTech. 2024 Jun 27. doi:10.1208/s12249-024-02852-4.
  3. Optimization of topical curcumin spanlastics for melanoma treatment
    • Authors: Soha Ismail, Doaa Garhy, Howida K. Ibrahim
    • Year: 2023
    • Citation: Ismail S, Garhy D, Ibrahim HK. Optimization of topical curcumin spanlastics for melanoma treatment. Pharmaceutical Development and Technology. 2023 May 28. doi:10.1080/10837450.2023.2204926.
  4. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation
    • Authors: Marwa H. Shukr, Soha Ismail, Ghada G. El-Hossary, Amany H. El-Shazly
    • Year: 2022
    • Citation: Shukr MH, Ismail S, El-Hossary GG, El-Shazly AH. Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation. Journal of Liposome Research. 2022 Oct 2. doi:10.1080/08982104.2022.2025828.
  5. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI
    • Authors: Marwa Farrag Abd El-Aziz, Soha Ismail, Mina Ibrahim Tadros, Mohamed Ahmed Elnabarawi
    • Year: 2020
    • Citation: Abd El-Aziz MF, Ismail S, Tadros MI, Elnabarawi MA. Alfuzosin hydrochloride-loaded low-density gastroretentive sponges: development, in vitro characterization and gastroretentive monitoring in healthy volunteers via MRI. Pharmaceutical Development and Technology. 2020 May 27. doi:10.1080/10837450.2020.1720235.
  6. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity
    • Authors: Marwa H. Shukr, Soha Ismail, Samya Mahmoud Ahmed
    • Year: 2019
    • Citation: Shukr MH, Ismail S, Ahmed SM. Development and optimization of ezetimibe nanoparticles with improved antihyperlipidemic activity. Journal of Drug Delivery Science and Technology. 2019 Feb. doi:10.1016/j.jddst.2018.12.001.
  7. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy
    • Authors: Dalia S. Shaker, Soha Ismail, Selwan Hamed, Eman M. El-Shishtawy
    • Year: 2018
    • Citation: Shaker DS, Ismail S, Hamed S, El-Shishtawy EM. Butoconazole nitrate vaginal sponge: Drug release and antifungal efficacy. Journal of Drug Delivery Science and Technology. 2018 Dec. doi:10.1016/j.jddst.2018.09

 

Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Posted on by Shen Awards

Dr. Kifayat Ullah Shah | Pharmaceutics | Best Researcher Award

Associate Professor at Quaid-i-Azam University, Pakistan

Dr. Kifayat Ullah Shah is an accomplished academic and researcher in the field of pharmaceutical sciences, currently serving as an Associate Professor at Quaid-e-Azam University in Islamabad since September 2014. He previously held positions as an Assistant Professor at Hamdard University and a Teaching Assistant at Gomal University. Dr. Shah earned his Ph.D. in Pharmaceutics from Gomal University, where he also completed his Bachelor of Pharmacy. His research interests include the formulation and development of pharmaceuticals, controlled drug delivery, and nanotechnology applications in drug delivery. He has authored several publications with significant impact, reflecting his contributions to the field, and has supervised over 35 MPhil and five PhD students. Dr. Shah has received grants for various research projects, showcasing his commitment to advancing pharmaceutical sciences. Additionally, he is actively involved in academic administration and quality assurance within higher education.

Profile

Education

Dr. Kifayat Ullah Shah holds an impressive educational background in pharmaceutical sciences. He earned his Doctor of Philosophy (Ph.D.) in Pharmaceutics from Gomal University, Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan, between 2008 and 2014. Prior to that, he obtained a Bachelor of Pharmacy (B.Pharmacy) degree from the same institution, Gomal University, from 2002 to 2006. His early education includes a Pre-Medical F.Sc. from Govt. P.G. College Bannu in 2000-2001 and Matriculation in Science from Govt. High School-02 Bannu in 1998-1999. This strong academic foundation has equipped Dr. Shah with the knowledge and skills necessary to excel in both research and teaching within the field of pharmaceutical sciences.

Professional Experience

Dr. Kifayat Ullah Shah has extensive professional experience in academia and the pharmaceutical industry. He has served as an Associate Professor at Quaid-e-Azam University, Islamabad, since September 2014, where he has contributed to teaching and research in pharmaceutical sciences. Prior to this role, Dr. Shah was an Assistant Professor at Hamdard University from January to August 2014 and worked as a Teaching Assistant at Gomal University for a brief period in late 2011. His early career included experience as a Production Pharmacist at Glitz Pharmaceuticals in Islamabad, where he gained practical insights into pharmaceutical production and formulation. Dr. Shah’s diverse professional background, coupled with his research focus on drug delivery systems and nanotechnology, has positioned him as a prominent figure in his field.

Research Interest

Dr. Kifayat Ullah Shah’s research interests are centered around the formulation and development of pharmaceutical products, with a particular focus on controlled drug delivery systems. His expertise encompasses a variety of advanced techniques, including microencapsulation, nanotechnology, and thermal analysis, which he applies to improve the efficacy and safety of drug formulations. Dr. Shah has conducted significant research on targeted drug delivery mechanisms, exploring innovative methods to enhance therapeutic outcomes for various medical conditions. His work also includes the design, preparation, and evaluation of controlled release polymeric formulations, aiming to investigate drug release patterns and mechanisms. Through his research, Dr. Shah seeks to contribute to the advancement of pharmaceutical sciences and improve patient care through effective drug delivery systems.

Research Skills

Dr. Kifayat Ullah Shah possesses a robust skill set in pharmaceutical research, particularly in the formulation and development of drug delivery systems. His expertise includes advanced techniques such as microencapsulation, controlled drug delivery, and targeted drug delivery, which are essential for optimizing the therapeutic effects of pharmaceuticals. Dr. Shah is proficient in utilizing various analytical instruments, including UV/Visible spectrophotometry, differential scanning calorimetry (DSC), and thermal analysis, to evaluate and characterize pharmaceutical formulations. His research skills also extend to pre-formulation studies and the application of nanotechnology in drug delivery, enabling him to design innovative solutions for complex pharmaceutical challenges. Through his comprehensive knowledge and practical experience, Dr. Shah effectively contributes to the advancement of pharmaceutical sciences and the development of new therapeutic strategies.

Award and Recognition

Dr. Kifayat Ullah Shah has garnered several awards and recognitions throughout his career, highlighting his significant contributions to the field of pharmaceutics. He successfully obtained funding for key research projects, including a grant of 0.5 million PKR from the Higher Education Commission (HEC) of Pakistan for the fabrication, characterization, and in vitro evaluation of finasteride nanoparticles. Additionally, he received a substantial grant of 4.5 million PKR for his project on silica-based nanoparticles as hemostatic agents for controlling internal bleeding. Dr. Shah has also been recognized for his academic excellence, having supervised over 35 MPhil and five PhD students, and for his impactful research publications, which have contributed to advancements in drug delivery systems. His work has earned him respect and acknowledgment in the academic and research communities, reflecting his dedication to enhancing pharmaceutical sciences and improving patient care.

Conclusion

Dr. Kifayat Ullah Shah’s impressive academic credentials, extensive research experience, impactful publications, successful funding acquisitions, and contributions to education and administrative services strongly position him as a deserving candidate for the Research for Best Researcher Award. His ongoing commitment to advancing pharmaceutical sciences through research and mentorship further strengthens his suitability for this recognition.

Publication Top Notes

  • “Non-pharmacological management of hypertension: in the light of current research”
    • Journal: Irish Journal of Medical Science (1971-)
    • Cited by: 180
    • Year: 2019
    • Volume: 188
    • Pages: 437-452
  • “From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)”
    • Journal: Expert Opinion on Drug Delivery
    • Cited by: 148
    • Year: 2017
    • Volume: 14, Issue 11
    • Pages: 1325-1340
  • “Proniosomes derived niosomes: recent advancements in drug delivery and targeting”
    • Journal: Drug Delivery
    • Cited by: 121
    • Year: 2017
    • Volume: 24, Issue 2
    • Pages: 56-69
  • “A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers”
    • Journal: Carbohydrate Polymers
    • Cited by: 106
    • Year: 2020
    • Volume: 250
    • Pages: 116800
  • “Elemental analysis of some medicinal plants used in traditional medicine by atomic absorption spectrophotometer (AAS)”
    • Journal: Journal of Medicinal Plants Research
    • Cited by: 93
    • Year: 2010
    • Volume: 4, Issue 19
    • Pages: 1987-1990
  • “Polymeric nanogels as versatile nanoplatforms for biomedical applications”
    • Journal: Journal of Nanomaterials
    • Cited by: 81
    • Year: 2019
    • Volume: 2019, Issue 1
    • Pages: 1526186
  • “Hemostatic strategies for uncontrolled bleeding: A comprehensive update”
    • Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials
    • Cited by: 73
    • Year: 2021
    • Volume: 109
  • “Development, in-vitro and in-vivo evaluation of ezetimibe-loaded solid lipid nanoparticles and their comparison with marketed product”
    • Journal: Journal of Drug Delivery Science and Technology
    • Cited by: 72
    • Year: 2019
    • Volume: 51
    • Pages: 583-590
  • “Prevalence of non-adherence to antihypertensive medication in Asia: a systematic review and meta-analysis”
    • Journal: International Journal of Clinical Pharmacy
    • Cited by: 56
    • Year: 2021
    • Volume: 43
    • Pages: 486-501
  • “Co-delivery strategies to overcome multidrug resistance in ovarian cancer”
    • Journal: International Journal of Pharmaceutics
    • Cited by: 47
    • Year: 2017
    • Volume: 533, Issue 1
    • Pages: 111-124
  • “Regulating drug release behavior and kinetics from matrix tablets based on fine particle‐sized ethyl cellulose ether derivatives: An in vitro and in vivo evaluation”
    • Journal: The Scientific World Journal
    • Cited by: 46
    • Year: 2012
    • Volume: 2012, Issue 1
    • Pages: 842348